Erectile dysfunction (ED) is increasingly prevalent in Japan, exceeding 30%, and increasing with age. Unhealthy lifestyle habits, obesity, insufficient exercise, and smoking have been implicated in its pathogenesis, along with endothelial dysfunction of the corpora cavernosa and impaired blood flow to the penis considered underlying factors. However, the current treatments are limited to Phosphodiesterase-5 (PDE5) inhibitors. ED is the primary symptom of andropathy. This study reports the clinical efficacy of human stem cell-conditioned medium cream for ED treatment. Ten men without underlying diseases suspected of andropause with ED (mean age 43.2 ± 4.4 y, Hb 15.2 ± 0.6 gm/dL, AST/ALT 30.2/37.9 ± 12.4/14.0, eGFR 82.7 ± 12.4 mL/min/1.73 m2) were targeted. The cream was applied twice daily to the genital and scrotal areas. The erectile hardness score (EHS), International Index of Erectile Function-5 (IIEF-5), and Aging Male Symptoms (AMS) scale were used to evaluate the participants before and 30 days after use, and the results were compared using paired t-tests. The post-use qualitative opinions were collected through interviews. Significant improvements were observed compared to baseline in the IIEF-5 (11.8 ± 4.6→17.2 ± 5.1, P < 0.001), and AMS (46.3 ± 6.7→37.6 ± 5.3, P < 0.001) scores post cream use. EHS did not show a statistically significant difference, but a trend towards improvement was observed. Qualitative feedback included increased morning erection, improved maintenance of erection during intercourse, and reduced post work fatigue. Human stem cell-conditioned medium contains endothelial growth factors that potentially contribute to the improvement of ED and andropause by enhancing corporal endothelial function. Future studies should include control groups to further investigate the efficacy of these treatments.
References
[1]
McCabe, M.P., Sharlip, I.D., Atalla, E., Balon, R., Fisher, A.D., Laumann, E., et al. (2016) Definitions of Sexual Dysfunctions in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. The Journal of Sexual Medicine, 13, 135-143. https://doi.org/10.1016/j.jsxm.2015.12.019
[2]
NIH Consensus Conference (1993) NIH Consensus Development on Impotence. JAMA, 270, 83-90.
[3]
Solomon, H. (2003) Erectile Dysfunction and the Cardiovascular Patient: Endothelial Dysfunction Is the Common Denominator. Heart, 89, 251-253. https://doi.org/10.1136/heart.89.3.251
[4]
Collinson, P. (2017) Erectile Dysfunction and Cardiovascular Disease: A Suitable Case for Treatment and Prevention? Heart, 103, 1231-1232. https://doi.org/10.1136/heartjnl-2017-311296
[5]
McCabe, M.P., Sharlip, I.D., Lewis, R., Atalla, E., Balon, R., Fisher, A.D., et al. (2016) Risk Factors for Sexual Dysfunction among Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. The Journal of Sexual Medicine, 13, 153-167. https://doi.org/10.1016/j.jsxm.2015.12.015
[6]
Kambou, T., Zaré, C., Paré, A.K., Ouattara, A., Somé, Y.L. and Sanon, B.G. (2014) Erectile Dysfunction among Diabetic Men in Two Medical Centers in Burkina Faso: Epidemiological, Diagnosis and Therapeutic Aspects. Advances in Sexual Medicine, 4, 1-5. https://doi.org/10.4236/asm.2014.41001
[7]
Diallo, Y., Kane, R., Kouka, S.C., Fall, B., Ondo, C.Z., N’Diaye, A., et al. (2015) Erectile Dysfunction: Clinical and Epidemiological Aspects in Senegal. Open Journal of Urology, 5, 147-154. https://doi.org/10.4236/oju.2015.59023
[8]
Fatusi, A.O., Ijadunola, K.T., Ojofeitimi, E.O., Adeyemi, M.O., Omideyi, A.K., Akinyemi, A., et al. (2003) Assessment of Andropause Awareness and Erectile Dysfunction among Married Men in Ile-Ife, Nigeria. The Aging Male, 6, 79-85. https://doi.org/10.1080/tam.6.2.79.85
[9]
Carson, C.C., Burnett, A.L., Levine, L.A. and Nehra, A. (2002) The Efficacy of Sildenafil Citrate (Viagra®) in Clinical Populations: An Update. Urology, 60, 12-27. https://doi.org/10.1016/s0090-4295(02)01687-4
[10]
Porst, H. (2002) IC351 (Tadalafil, Cialis): update on clinical experience. International Journal of Impotence Research, 14, S57-S64. https://doi.org/10.1038/sj.ijir.3900807
[11]
Hatzichristou, D. (2005) Phosphodiesterase 5 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy (NAION): Coincidence or Causality? The Journal of Sexual Medicine, 2, 751-758. https://doi.org/10.1111/j.1743-6109.2005.00144.x
[12]
Hattenhauer, M.G., Leavitt, J.A., Hodge, D.O., Grill, R. and Gray, D.T. (1997) Incidence of Nonarteritic Anteripr Ischemic Optic Neuropathy. American Journal of Ophthalmology, 123, 103-107. https://doi.org/10.1016/s0002-9394(14)70999-7
[13]
Khan, A.S., Sheikh, Z., Khan, S., Dwivedi, R. and Benjamin, E. (2011) Viagra Deafness—Sensorineural Hearing Loss and Phosphodiesterase-5 Inhibitors. The Laryngoscope, 121, 1049-1054. https://doi.org/10.1002/lary.21450
[14]
Pegge, N.C., Twomey, A.M., Vaughton, K., Gravenor, M.B., Ramsey, M.W. and Price, D.E. (2006) The Role of Endothelial Dysfunction in the Pathophysiology of Erectile Dysfunction in Diabetes and in Determining Response to Treatment. Diabetic Medicine, 23, 873-878. https://doi.org/10.1111/j.1464-5491.2006.01911.x
[15]
Deyoung, L., Chung, E., Kovac, J.R., Romano, W. and Brock, G.B. (2012) Daily Use of Sildenafil Improves Endothelial Function in Men with Type 2 Diabetes. Journal of Andrology, 33, 176-180. https://doi.org/10.2164/jandrol.111.013367
[16]
Rosen, R.C., Riley, A., Wagner, G., Osterloh, I.H., Kirkpatrick, J. and Mishra, A. (1997) The International Index of Erectile Function (IIEF): A Multidimensional Scale for Assessment of Erectile Dysfunction. Urology, 49, 822-830. https://doi.org/10.1016/s0090-4295(97)00238-0
[17]
Mulcahy, M.J. and Greenfield, J.M. (1994) The Erectile Hardness Score: A Simple, Objective Measure of Erectile Function. Journal of Urology, 151, 1528-1532.
[18]
Salonia, A., Fabbri, A., and Melis, G.B. (2000) The Aging Male Symptoms (AMS) scale: A New Tool for the Assessment of Androgen Deficiency in Aging Males. Journal of Andrology, 21, 213-218.
[19]
Kanda, Y. (2012) Investigation of the Freely Available Easy-To-Use Software ‘EZR’ for Medical Statistics. Bone Marrow Transplantation, 48, 452-458. https://doi.org/10.1038/bmt.2012.244
[20]
Koga, S. and Horiguchi, Y. (2021) Efficacy of a Cultured Conditioned Medium of Exfoliated Deciduous Dental Pulp Stem Cells in Erectile Dysfunction Patients. Journal of Cellular and Molecular Medicine, 26, 195-201. https://doi.org/10.1111/jcmm.17072
[21]
Pérez-Aizpurua, X., Garranzo-Ibarrola, M., Simón-Rodríguez, C., García-Cardoso, J.V., Chávez-Roa, C., López-Martín, L., et al. (2023) Stem Cell Therapy for Erectile Dysfunction: A Step towards a Future Treatment. Life, 13, Article 502. https://doi.org/10.3390/life13020502
[22]
Kato, M., Tsunekawa, S., Nakamura, N., Miura-Yura, E., Yamada, Y., Hayashi, Y., et al. (2020) Secreted Factors from Stem Cells of Human Exfoliated Deciduous Teeth Directly Activate Endothelial Cells to Promote All Processes of Angiogenesis. Cells, 9, Article 2385. https://doi.org/10.3390/cells9112385
[23]
Pakpahan, C., Ibrahim, R., William, W., Faizah, Z., Juniastuti, J., Lusida, M.I., et al. (2021) Stem Cell Therapy and Diabetic Erectile Dysfunction: A Critical Review. World Journal of Stem Cells, 13, 1549-1563. https://doi.org/10.4252/wjsc.v13.i10.1549
[24]
Hou, J., Xin, Z., Zhou, F., Hui, Y., Xin, H., Xu, Y., et al. (2017) Therapeutic Effects of Adipose-Derived Stem Cells-Based Microtissues on Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats. Asian Journal of Andrology, 19, 91-97. https://doi.org/10.4103/1008-682x.182817
